ArticleBMJ open2026

Semaglutide for prevention of type 2 diabetes in women with postpartum prediabetes after gestational diabetes: protocol for a Belgian multicentre double-blind randomised placebo-controlled trial.

Yana Vanlaer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.